Clinical trial

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer

NCT00668642

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-03-01

PhasePHASE2

Study timeline

Study start (actual)2007-03-01Date precision: month

Registry last updated2023-08-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

DutasterideDRUG · verified · RxNorm: dutasteride

PlaceboDRUG

Sponsors & collaborators

Endeavor Healthlead sponsor

University of Chicagocollaborator

Northwestern Universitycollaborator

Mapped research locations

ChicagoIllinois, United States2 EvanstonIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00668642 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.